Yanan Jiang

10PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 25, 2026
The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies.

|Nov 07, 2025
CERS6 promotes esophageal squamous cell carcinoma proliferation by increasing the stability of RPN1.

Wenjing Chen, Yuxin Zhai, Xiaoxiao Yang

|Apr 13, 2025
SRPK1 Activation Facilitates Gli3<sup>S664</sup> Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma.

Yongwei Ding, Jiace Qin, Mengjia Zhang

|Sep 17, 2024
DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability.

Yunshu Shi, Junyong Wang, Qiang Yuan

|Jun 16, 2023
TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway.

Wenjie Wu, Jialuo Xu, Dan Gao

|May 05, 2023
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC.

Mingzhu Li, Lina Duan, Wenjie Wu

Pageof 2

Frequent Collaborators

8 joint publications

Kangdong Liu

7 joint publications

Zigang Dong

5 joint publications

Jimin Zhao

2 joint publications

Zhuo Bao